Patterns of sleep breathing disorders among patients with interstitial lung disease.

A new emphasis has been placed on the correlation between sleep and outcomes in interstitial lung disease (ILD) cases recently. According to new studies, sleep disorders are prevalent and common in interstitial lung disease cohorts and appear to have a significant adverse effect on survival, disease development, and quality of life (QOL). Obstructive sleep apnea (OSA) is prevalent in 44–72% of interstitial lung disease cases, and nocturnal hypoxemia (NH) is quite prevalent in the OSA absence. Sleep disordered breathing is an ILD case’s common feature. In ILD, sleep disturbs are linked to a lower QOL and may also indicate a more accelerated progression in the disease and a rise in mortality. The potential for NH to contribute to the progression of ILD is still uncertain. Despite the fact that uncontrolled and retrospective studies have suggested that managing OSA may enhance ILD-related effects, prospective studies are scarce in this field.